Memorial Sloan Kettering Cancer Center
Breast
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Combined With Abemaciclib in ER+/HER2- aBC
FEATURING
Komal Jhaveri
- 253 views
- January 8, 2025
- 1
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpelisib, in ER+/HER2- Advanced BC"
FEATURING
Komal Jhaveri
- 160 views
- December 1, 2023
- 2
Memorial Sloan Kettering Cancer Center
Early Diagnosis and Updates in Breast Cancer
FEATURING
Virgilio Sacchini
- 172 views
- November 10, 2023
- 1
Nebraska Oncology Society
ASCO 2022 HR+ Breast Cancer Updates
FEATURING
Chau Dang
- 601 views
- July 6, 2022
- 2
Nebraska Oncology Society
ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates
FEATURING
Chau Dang
- 57 views
- July 6, 2022
Nebraska Oncology Society
ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates
FEATURING
Chau Dang
- 77 views
- July 6, 2022
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection for At-Home Administration in HER2+ BC During the COVID-19 Pandemic
FEATURING
Chau Dang
- 43 views
- June 21, 2022
ecancer
ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MBC With Low HER2 Expression
FEATURING
Shanu Modi
- 44 views
- June 17, 2022
ecancer
ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of Physician’s Choice in Pts With HER2-Low Unresectable/Metastatic BC
FEATURING
Shanu Modi
- 224 views
- June 17, 2022
- 1
ASCO 2022 Conference Coverage
ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC
FEATURING
Sherry Shen
- 370 views
- June 8, 2022
- 1
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC
FEATURING
Sherry Shen
- 18 views
- June 8, 2022
Memorial Sloan Kettering Cancer Center
HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Breast Cancer
FEATURING
Neil Iyengar
- 663 views
- March 15, 2022
- 2
University of Kansas Cancer Center Post San Antonio Review
2022 Inherited Breast Cancer Risk Assessment and Reduction: What's New
FEATURING
Mark Robson
- 48 views
- February 23, 2022
PleXus Communications
HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors
FEATURING
Komal Jhaveri
- 347 views
- February 9, 2022
SABCS 2021 Conference Coverage on VuMedi
SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locally More Than Systemically
FEATURING
Amy Xu
- 509 views
- December 15, 2021
- 6
Memorial Sloan Kettering Cancer Center
Will Surgery Be a Part of Breast Cancer Treatment in the Future?
FEATURING
Monica Morrow
- 3,849 views
- December 23, 2019
- 21
